» Articles » PMID: 35604347

Generation of a Mouse Model of the Neurodevelopmental Disorder with Dysmorphic Facies and Distal Limb Anomalies Syndrome

Overview
Journal Hum Mol Genet
Date 2022 May 23
PMID 35604347
Authors
Affiliations
Soon will be listed here.
Abstract

Heterozygous variants in bromodomain and plant homeodomain containing transcription factor (BPTF) cause the neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL) syndrome (MIM#617755) characterized by intellectual disability, speech delay and postnatal microcephaly. BPTF functions within nucleosome and remodeling factor (NURF), a complex comprising sucrose non-fermenting like (SNF2L), an Imitation SWItching (ISWI) chromatin remodeling protein encoded by the SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 (SMARCA1) gene. Surprisingly, ablation of Smarca1 resulted in mice with enlarged brains, a direct contrast to the phenotype of NEDDFL patients. To model the NEDDFL syndrome, we generated forebrain-specific Bptf knockout (Bptf conditional Knockout (cKO)) mice. The Bptf cKO mice were born in normal Mendelian ratios, survived to adulthood but were smaller in size with severe cortical hypoplasia. Prolonged progenitor cell cycle length and a high incidence of cell death reduced the neuronal output. Cortical lamination was also disrupted with reduced proportions of deep layer neurons, and neuronal maturation defects that impaired the acquisition of distinct cell fates (e.g. COUP-TF-interacting protein 2 (Ctip2)+ neurons). RNAseq and pathway analysis identified altered expression of fate-determining transcription factors and the biological pathways involved in neural development, apoptotic signaling and amino acid biosynthesis. Dysregulated genes were enriched for MYC Proto-Oncogene, BHLH Transcription Factor (Myc)-binding sites, a known BPTF transcriptional cofactor. We propose the Bptf cKO mouse as a valuable model for further study of the NEDDFL syndrome.

Citing Articles

Pathogenic variants in SMARCA1 cause an X-linked neurodevelopmental disorder modulated by NURF complex composition.

Picketts D, Mirzaa G, Yan K, Relator R, Timpano S, Yalcin B Res Sq. 2023; .

PMID: 37841849 PMC: 10571636. DOI: 10.21203/rs.3.rs-3317938/v1.


The effect of growth hormone treatment in children with novel BPTF gene variants: A report of two cases and literature review.

Wu W, Chen R Mol Genet Genomic Med. 2022; 11(1):e2066.

PMID: 36153657 PMC: 9834177. DOI: 10.1002/mgg3.2066.

References
1.
Bogershausen N, Wollnik B . Mutational Landscapes and Phenotypic Spectrum of SWI/SNF-Related Intellectual Disability Disorders. Front Mol Neurosci. 2018; 11:252. PMC: 6085491. DOI: 10.3389/fnmol.2018.00252. View

2.
Kwon S, Grisan V, Jang B, Herbert J, Badenhorst P . Genome-Wide Mapping Targets of the Metazoan Chromatin Remodeling Factor NURF Reveals Nucleosome Remodeling at Enhancers, Core Promoters and Gene Insulators. PLoS Genet. 2016; 12(4):e1005969. PMC: 4821604. DOI: 10.1371/journal.pgen.1005969. View

3.
Clapier C, Iwasa J, Cairns B, Peterson C . Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol. 2017; 18(7):407-422. PMC: 8127953. DOI: 10.1038/nrm.2017.26. View

4.
Tuoc T, Boretius S, Sansom S, Pitulescu M, Frahm J, Livesey F . Chromatin regulation by BAF170 controls cerebral cortical size and thickness. Dev Cell. 2013; 25(3):256-69. DOI: 10.1016/j.devcel.2013.04.005. View

5.
Goller T, Vauti F, Ramasamy S, Arnold H . Transcriptional regulator BPTF/FAC1 is essential for trophoblast differentiation during early mouse development. Mol Cell Biol. 2008; 28(22):6819-27. PMC: 2573307. DOI: 10.1128/MCB.01058-08. View